FDA Device Intelligence
HomeDRG Instruments Gesellschaft mit beschränkter Haftung › Androstenedione ELISA

Androstenedione ELISA

DRG Instruments Gesellschaft mit beschränkter Haftung · Model EIA-3265 · UDI-DI 04048474032659

CIZ Prescription
10
510(k) clearances
125
Adverse events
5
Recalls
20
Facilities

Description

The DRG Androstenedione ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Androstenedione in serum and EDTA plasma.

Recalls

DateFirmReason
2014-06-09Siemens Healthcare Diagnostics Inc.The assay is demonstrating a higher frequency of results greater than 10 ng/mL compared to alternate platforms.
2013-12-20Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics confirmed over-recovery of samples with concentrations greater than 5.5 ng/mL with the IMMULITE/IMMULITE 1000 and IMMULITE 2000/IMMULITE 2000 XPi And
2013-12-20Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics confirmed over-recovery of samples with concentrations greater than 5.5 ng/mL with the IMMULITE/IMMULITE 1000 and IMMULITE 2000/IMMULITE 2000 XPi And
2004-07-15Diasorin Inc.Standards used in the GammaCoat Androstenedione Radioimmunoassay Kit appeared yellowish in color and were gelatinous upon reconstitution.
2004-05-25Diasorin Inc.Standards contained in the GammaCoat Androstenedione RIA Kit appeared yellowish in color and were gelatinous upon reconstitution. The assay validation criteria failed when the gel

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.